Paul Herrling
Paul Herrling is the head of corporate research at Novartis and the chairman of board of the Novartis Institute for Tropical Diseases, Singapore since 2002. Prior to this, he was the head of Global Research of Novartis Pharma.Paul Herrling is also Professor of Drug Discovery Science at the University of Basel, Switzerland and Full Adjunct Professor at the Harold Dorris Neurobiological Institute, Scripps Research Institute, La Jolla, California.
He obtained his Ph.D. in 1975 at the University of Zurich and was a post-doctorate fellow at the UCLA Neuropsychiatric Institute. Provided by Wikipedia
1
by Manu De Rycker, David Horn, Bree Aldridge, Richard K. Amewu, Clifton E. Barry, Frederick S. Buckner, Sarah Cook, Michael A.J. Ferguson, Nathalie Gobeau, Jennifer Herrmann, Paul Herrling, William Hope, Jennifer Keiser, Maria Jose Lafuente-Monasterio, Paul D. Leeson, Didier Leroy, Ujjini H. Manjunatha, James McCarthy, Timothy J. Miles, Valerie Mizrahi, Olena Moshynets, Jacquin Niles, John P. Overington, John Pottage, Srinivasa P.S. Rao, Kevin D. Read, Isabela Ribeiro, Lynn L. Silver, Jen Southern, Thomas Spangenberg, Shyam Sundar, Caitlin Taylor, Wes Van Voorhis, Nicholas J. White, Susan Wyllie, Paul G. Wyatt, Ian H. Gilbert
Published 2020
Get full textPublished 2020
Review